Input feed: Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items
Sort by:
Date tagged
Date published
-
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
https://api.zotero.org/groups/2494380/items/7PELS3CQ?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 09/23/2020
-
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial. | medRxiv preprints (not peer reviewed)
https://api.zotero.org/groups/2494380/items/TAVF2BHL?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 09/23/2020
-
Voices from the frontline: findings from a thematic analysis of a rapid online global survey of maternal and newborn health professionals facing the COVID-19 pandemic
https://api.zotero.org/groups/2494380/items/ISIWS55P?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 09/23/2020
-
An affordable anti-SARS-COV-2 spike protein ELISA test for early detection of IgG seroconversion suited for large-scale surveillance studies in low-income countries | medRxiv preprints (not peer reviewed)
https://api.zotero.org/groups/2494380/items/M6ELX99Q?format=atom
Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 09/23/2020